Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation.

Tarnowski M, Słuczanowska-Głabowska S, Pawlik A, Mazurek-Mochol M, Dembowska E.

Ther Clin Risk Manag. 2017 Apr 6;13:439-446. doi: 10.2147/TCRM.S129327. eCollection 2017. Review.

2.

Genetic variants in KCNJ11, TCF7L2 and HNF4A are associated with type 2 diabetes, BMI and dyslipidemia in families of Northeastern Mexico: A pilot study.

Gallardo-Blanco HL, Villarreal-Perez JZ, Cerda-Flores RM, Figueroa A, Sanchez-Dominguez CN, Gutierrez-Valverde JM, Torres-Muñoz IC, Lavalle-Gonzalez FJ, Gallegos-Cabriales EC, Martinez-Garza LE.

Exp Ther Med. 2017 Feb;13(2):523-529. doi: 10.3892/etm.2016.3990. Epub 2016 Dec 22.

3.

Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.

Rizvi S, Raza ST, Rahman Q, Mahdi F.

3 Biotech. 2016 Dec;6(2):255. doi: 10.1007/s13205-016-0572-x. Epub 2016 Dec 2. Review.

4.

Association between TCF7L2 polymorphisms and gestational diabetes mellitus: A meta-analysis.

Chang S, Wang Z, Wu L, Lu X, Shangguan S, Xin Y, Li L, Wang L.

J Diabetes Investig. 2017 Jul;8(4):560-570. doi: 10.1111/jdi.12612. Epub 2017 Feb 28.

5.

Genetic Determinants of Type 2 Diabetes in Asians.

Qi Q, Wang X, Strizich G, Wang T.

Int J Diabetol Vasc Dis Res. 2015;2015(Suppl 1). doi: 10.19070/2328-353X-SI01001. Epub 2015 Mar 12.

6.

TNIK inhibition abrogates colorectal cancer stemness.

Masuda M, Uno Y, Ohbayashi N, Ohata H, Mimata A, Kukimoto-Niino M, Moriyama H, Kashimoto S, Inoue T, Goto N, Okamoto K, Shirouzu M, Sawa M, Yamada T.

Nat Commun. 2016 Aug 26;7:12586. doi: 10.1038/ncomms12586.

7.

TarNet: An Evidence-Based Database for Natural Medicine Research.

Hu R, Ren G, Sun G, Sun X.

PLoS One. 2016 Jun 23;11(6):e0157222. doi: 10.1371/journal.pone.0157222. eCollection 2016.

8.

Candidate gene analysis supports a role for polymorphisms at TCF7L2 as risk factors for type 2 diabetes in Sudan.

Ibrahim AT, Hussain A, Salih MA, Ibrahim OA, Jamieson SE, Ibrahim ME, Blackwell JM, Mohamed HS.

J Diabetes Metab Disord. 2016 Mar 1;15:4. doi: 10.1186/s40200-016-0225-y. eCollection 2015.

9.

A HuGE Review and Meta-Analyses of Genetic Associations in New Onset Diabetes after Kidney Transplantation.

Benson KA, Maxwell AP, McKnight AJ.

PLoS One. 2016 Jan 20;11(1):e0147323. doi: 10.1371/journal.pone.0147323. eCollection 2016. Review.

10.

Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?

Pollastro C, Ziviello C, Costa V, Ciccodicola A.

PPAR Res. 2015;2015:415149. doi: 10.1155/2015/415149. Epub 2015 Jun 15. Review.

11.

The association between the FABP2 Ala54Thr variant and the risk of type 2 diabetes mellitus: a meta-analysis based on 11 case-control studies.

Liu P, Yu D, Jin X, Li C, Zhu F, Zheng Z, Lv C, He X.

Int J Clin Exp Med. 2015 Apr 15;8(4):5422-9. eCollection 2015.

12.

Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study.

Nanfa D, Sobngwi E, Atogho-Tiedeu B, Noubiap JJ, Donfack OS, Mofo EP, Guewo-Fokeng M, Nguimmo Metsadjio A, Ndonwi Ngwa E, Pokam Fosso P, Djahmeni E, Djokam-Dadjeu R, Evehe MS, Aminkeng F, Mbacham WF, Mbanya JC.

Clin Transl Med. 2015 Apr 23;4:17. doi: 10.1186/s40169-015-0058-1. eCollection 2015.

13.

Validation of the association of TCF7L2 and SLC30A8 gene polymorphisms with post-transplant diabetes mellitus in Asian Indian population.

Khan IA, Jahan P, Hasan Q, Rao P.

Intractable Rare Dis Res. 2015 May;4(2):87-92. doi: 10.5582/irdr.2015.01008.

14.

Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon.

Guewo-Fokeng M, Sobngwi E, Atogho-Tiedeu B, Donfack OS, Noubiap JJ, Ngwa EN, Mato-Mofo EP, Fosso PP, Djahmeni E, Djokam-Dadjeu R, Evehe MS, Aminkeng F, Mbacham WF, Mbanya JC.

J Diabetes Metab Disord. 2015 Apr 14;14:26. doi: 10.1186/s40200-015-0148-z. eCollection 2015.

15.

Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast.

Frey JL, Li Z, Ellis JM, Zhang Q, Farber CR, Aja S, Wolfgang MJ, Clemens TL, Riddle RC.

Mol Cell Biol. 2015 Jun 1;35(11):1979-91. doi: 10.1128/MCB.01343-14. Epub 2015 Mar 23.

16.

The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice.

Kumar A, Shiloach J, Betenbaugh MJ, Gallagher EJ.

Nutr Metab (Lond). 2015 Mar 8;12:8. doi: 10.1186/s12986-015-0003-8. eCollection 2015.

17.

Genetics of type 2 diabetes-pitfalls and possibilities.

Prasad RB, Groop L.

Genes (Basel). 2015 Mar 12;6(1):87-123. doi: 10.3390/genes6010087. Review.

18.

Role of Established Type 2 Diabetes-Susceptibility Genetic Variants in a High Prevalence American Indian Population.

Hanson RL, Rong R, Kobes S, Muller YL, Weil EJ, Curtis JM, Nelson RG, Baier LJ.

Diabetes. 2015 Jul;64(7):2646-57. doi: 10.2337/db14-1715. Epub 2015 Feb 9.

19.
20.

The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population.

Ouhaibi-Djellouli H, Mediene-Benchekor S, Lardjam-Hetraf SA, Hamani-Medjaoui I, Meroufel DN, Boulenouar H, Hermant X, Saidi-Mehtar N, Amouyel P, Houti L, Goumidi L, Meirhaeghe A.

BMC Genet. 2014 Dec 10;15:134. doi: 10.1186/s12863-014-0134-3.

Supplemental Content

Support Center